Ampersand Biomedicines
Home - Ampersand
Cambridge, United States · Founded 2021 · $115.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 1–10
- Founded
- 2021
- Business Model
- B2B
- Website
- ampersand.bio
- Total Funding
- $115.0M
- Last Round
- $65.0M Series BMar 2025
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
Biotech company developing AND-Body medicines that combine localizers and potent actuators for precise disease targeting.
Summary
Ampersand Biomedicines is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $115.0M in total across 2 rounds, most recently a $65.0M Series B round in Mar 2025. Investors include Flagship Pioneering and Eli Lilly.
Tech & App Stack
6 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Mar 2025
Sign up to see all 2 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Simtra provides pharmaceutical and biotech clients development and manufacturing services for ste...
Global contract research organization providing comprehensive drug development and laboratory ser...
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Specialty pharmaceutical company
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/ampersand-biomedicines"><img src="https://indexed.vc/api/badge/company/ampersand-biomedicines" alt="Ampersand Biomedicines on Indexed.vc" width="260" height="76" /></a>